 |
 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Development of Type 2 Diabetes among People Participating in a Program To Promote Healthy Behaviors
1 March 2005 | Volume 142 Issue 5 | Page I-17
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
The summary below is from the full report titled "Incidence of Type 2 Diabetes in the Randomized Multiple Risk Factor Intervention Trial." It is in the 1 March 2005 issue of Annals of Internal Medicine (volume 142, pages 313-322). The authors are G. Davey Smith, Y. Bracha, K.H. Svendsen, J.D. Neaton, S.M. Haffner, and L.H. Kuller, for the Multiple Risk Factor Intervention Trial Research Group.
What is the problem and what is known about it so far?
Type 2 diabetes (adult-onset diabetes) interferes with the body's ability to store energy from food. The result is high levels of blood sugar. Over time, high blood sugar levels lead to complications such as blindness, kidney failure, and heart disease. Many people with type 2 diabetes have moderately high levels of blood sugar for years before the levels reach true diabetes levels and symptoms begin. This condition is called abnormal glucose tolerance or prediabetes. Diet and exercise can prevent or delay the development of type 2 diabetes in people with prediabetes. However, no definitive studies have shown whether healthy behaviors also reduce type 2 diabetes in people without prediabetes.
Why did the researchers do this particular study?
To find out whether a program to promote healthy diet and exercise behavior would reduce the development of type 2 diabetes in people without prediabetes.
Who was studied?
11,827 men without prediabetes who were participating in a large study called the Multiple Risk Factor Intervention Trial (MRFIT). The main purpose of the MRFIT study was to examine the effect of changes in health behaviors on the development of heart disease.
How was the study done?
The researchers assigned men in the study to receive either usual health care or a special program that involved counseling to reduce fat and calorie intake, stop smoking, and increase physical activity. Men in the special program also received more intensive treatment of blood pressure than men in the usual care group. The researchers followed the men for 6 to 7 years to see who developed type 2 diabetes. They examined results separately for smokers and nonsmokers.
What did the researchers find?
Similar numbers of men in both groups developed type 2 diabetes. However, nonsmokers who participated in the special program were less likely to develop diabetes than those who received usual care.
What were the limitations of the study?
The researchers did not plan the separate analyses of smokers and nonsmokers from the beginning of the study, so these findings are preliminary. In addition, the study included only men, so the findings might not apply to women.
What are the implications of the study?
A special program to promote healthy diet and exercise behaviors can reduce the development of type 2 diabetes for nonsmokers without prediabetes. The special program did not reduce type 2 diabetes among smokers without prediabetes, and this emphasizes the need to maintain adequate weight control after stopping smoking.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  W T. Cade Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting Physical Therapy, November 1, 2008; 88(11): 1322 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Choi, M. A. De Vera, and E. Krishnan Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile Rheumatology, October 1, 2008; 47(10): 1567 - 1570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Carter, P. T. Einhorn, M. Brands, J. He, J. A. Cutler, P. K. Whelton, G. L. Bakris, F. L. Brancati, W. C. Cushman, S. Oparil, et al. Thiazide-Induced Dysglycemia: Call for Research From a Working Group From the National Heart, Lung, and Blood Institute Hypertension, July 1, 2008; 52(1): 30 - 36. [Full Text] [PDF]
|
|
|
|
 |
|
 F. H. Messerli, S. Bangalore, and S. Julius Risk/Benefit Assessment of {beta}-Blockers and Diuretics Precludes Their Use for First-Line Therapy in Hypertension Circulation, May 20, 2008; 117(20): 2706 - 2715. [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Wangberg An Internet-based diabetes self-care intervention tailored to self-efficacy Health Educ. Res., February 1, 2008; 23(1): 170 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bangalore, F. H. Messerli, J. B. Kostis, and C. J. Pepine Cardiovascular Protection Using Beta-Blockers: A Critical Review of the Evidence J. Am. Coll. Cardiol., August 14, 2007; 50(7): 563 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A.M. Jacobs-van der Bruggen, G. Bos, W. J. Bemelmans, R. T. Hoogenveen, S. M. Vijgen, and C. A. Baan Lifestyle Interventions Are Cost-Effective in People With Different Levels of Diabetes Risk: Results from a modeling study Diabetes Care, January 1, 2007; 30(1): 128 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Hamman, R. R. Wing, S. L. Edelstein, J. M. Lachin, G. A. Bray, L. Delahanty, M. Hoskin, A. M. Kriska, E. J. Mayer-Davis, X. Pi-Sunyer, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care, September 1, 2006; 29(9): 2102 - 2107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Colagiuri, S. Colagiuri, D. Yach, and S. Pramming The Answer to Diabetes Prevention: Science, Surgery, Service Delivery, or Social Policy? Am J Public Health, September 1, 2006; 96(9): 1562 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Sedor and J. R. Schelling Association of Metabolic Syndrome in Nondiabetic Patients with Increased Risk for Chronic Kidney Disease: The Fat Lady Sings J. Am. Soc. Nephrol., July 1, 2005; 16(7): 1880 - 1882. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Goldfarb Lowering Risks Pays Off for Nondiabetic Patients DOC News, May 1, 2005; 2(5): 1 - 8. [Full Text]
|
|
|
|
 |
|
 Endocrinology & Metabolism News April 2005 J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 16a - 16a. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tonks What's new in the other general journals BMJ, March 12, 2005; 330(7491): 561 - 562. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tuomilehto Primary Prevention of Type 2 Diabetes: Lifestyle Intervention Works and Saves Money, but What Should Be Done with Smokers? Ann Intern Med, March 1, 2005; 142(5): 381 - 383. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
